HHSN27500006

IGF::OT::IGF CCTN- MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL HHSN275201300025I/HHSN27500006

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	NATIONAL INSTITUTES OF HEALTH NICHD
NAICS	541712
PSC	AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicle	HHSN275201300025I
Set-aside	Not reported
Pricing type	COST NO FEE
Obligations	$7.7M
Current contract value	$7.7M
Potential contract value / ceiling	$7.7M
Start date	Sep 14, 2015
Current end date	Dec 31, 2026
Potential end date	Dec 31, 2026
Latest award activity	Dec 11, 2025
Source loaded	Sep 26, 2026

Funding and modification history

Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Dec 11, 2025	P00009	$0	NICHD: R&D: CLINICAL EVALUATION OF NES TES GEL FOR MALE CONTRACEPTION: NON-SEVERABLE
Sep 25, 2024	P00008	$0	CCTN MALE SITES - UW TASK 6, CLINICAL EVALUATION OF NES TES GEL FOR MALE CONTRACEPTION
Mar 23, 2023	P00007	$1.5M	CCTN MALE SITES - UW TASK 6, CLINICAL EVALUATION OF NES TES GEL FOR MALE CONTRACEPTION
Jun 30, 2022	P00006	$1.2M	CCTN MALE SITES - UW TASK 6, CLINICAL EVALUATION OF NES TES GEL FOR MALE CONTRACEPTION
Jun 9, 2022	P00005	$0	CCTN MALE SITES - UW TASK 6, CLINICAL EVALUATION OF NES TES GEL FOR MALE CONTRACEPTION
Sep 25, 2020	P00004	$0	CCTN MALE SITES - UW TASK 6, CLINICAL EVALUATION OF NES TES GEL FOR MALE CONTRACEPTION, EXTEND PERFORMANCE TO 9/15/23 AND ADD FUNDS.
Jun 19, 2020	P00003	$2.6M	CCTN MALE SITES - UW TASK 6, CLINICAL EVALUATION OF NES TES GEL FOR MALE CONTRACEPTION, EXTEND PERFORMANCE TO 9/15/23 AND ADD FUNDS.
Feb 8, 2018	P00002	$0	IGF::OT::IGF CCTN- MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL HHSN275201300025I/HHSN27500006
Aug 22, 2016	1	$0	IGF::OT::IGF CCTN- MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL HHSN275201300025I/HHSN27500006
Sep 14, 2015	0	$2.4M	IGF::OT::IGF CCTN- MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL HHSN275201300025I/HHSN27500006

Estimated positioning window

Nov 1, 2026 – Jan 30, 2027

Recompete signal:

75/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 75/100. Available recorded signals: 70 points.

Contract end 2026-12-31 (60 days from calculation): +35 points
58 historical awards in this buyer and category group: +15 points
10 recorded award transactions: +10 points
Latest award action: 2025-12-11: +5 points
Parent award identifier recorded: +5 points
Solicitation identifier recorded: +0 points
Linked official forecast: +0 points
Calculated on: 2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Confirm the ordering vehicle and your eligibility or a qualified teaming route.
Review the award scope and buyer evidence before making a bid/no-bid decision.